Late-Onset Neutropenia After Rituximab in Multiple Sclerosis: Incidence, Predictors, and Outcomes in a Retrospective Multicenter Cohort.

Hallberg S, Kallin S, Evertsson B, Boremalm M, de Flon P, Salzer J, Lycke J, Fink K, Svenningsson A

Neurol Neuroimmunol Neuroinflamm. 2026 Nov; 13(6):e200642. PMID: 42743451. Abstract